Drug Trial Radar · NCT06260709
A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis
Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
88
Planned (sponsor's estimate)
Start
Feb 20, 2024
Primary completion
Feb 29, 2028
Study completion Feb 9, 2030
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Feb 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe this medicine is in the long term and if it can reduce symptoms of a heart disease due to TTR amyloidosis, such as heart failure. It is an extension to a study called "A research study to look at how a new medicine called NNC6019-0001 works and how safe it is for people who have a heart disease due to TTR amyloidosis". Only participants who have completed that study will be invited for this new study. Participants will get NNC6019-0001, regardless of whether they got placebo or NNC6019-0001 in the first study. The study will last for approximately 6 years or until NNC6019-0001 is commercially or otherwise available to the participant, whichever comes first.
Conditions
- Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Interventions
NNC6019-0001Drug
Intravenous NNC6019-0001 every 4 weeks added to the standard of care up to 300 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Treatment Emergent Adverse Events (TEAEs)Time frame: From baseline (week 0) to up to 6 years
Locations
38 sites in 10 countries. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Phoenix, Arizona
Cedars-Sinai Medical Center_Los Angeles
Los Angeles, California
Stanford Hlth Cre-Boswell Clin
Stanford, California
Mayo Clinic Jacksonville
Jacksonville, Florida
NW Univ-Bluhm Cardiovasc Inst
Chicago, Illinois
NW Univ-Bluhm Cardiovasc Inst
Evanston, Illinois
Univ of MD Schl of Med
Baltimore, Maryland
Mayo Clinic Rochester
Rochester, Minnesota
University of Calgary_Cardiology
Calgary, Alberta, Canada
Ctr for Cardiovascular Innovation
Vancouver, British Columbia, Canada
II. interni klinika VFN - Kardiologie a angiologie
Prague, Czechia
Ap-Hp-Hopital Henri Mondor
Créteil, France
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1
Toulouse, France
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil
Toulouse, France
UniklinikHeidelberg - Innere Med. III - Kardiologie, Angiologie, Pneumologie
Heidelberg, Germany
Universitätsklinik Heidelberg Innere Medizin III Kardiologie, Angiologie, Pneumologie
Heidelberg, Germany
LMU Klinikum München Klinik und Poliklinik 1
München, Germany
Uniklinik Münster, Klinik für Kardiologie I
Münster, Germany
Universitätsklinikum Münster - Klinik für Kardiologie I
Münster, Germany
Universitatsklinikum Wurzburg AöR
Würzburg, Germany
Universitatsklinikum Würzburg - Zentrum für Herzinsuffizienz
Würzburg, Germany
Fondazione CNR-Regione Toscana Gabriele Monasterio
Pisa, Pi, Italy
Fondazione Toscana Gabriele Monasterio - Dipartimento Cardiotoracico - UOC Cardiologia e Medicina Cardiovascolare
Pisa, Pi, Italy
Centro per lo Studio e la Cura delle Amiloidosi Sistemiche Fondazione IRCCS Policlinico San Matteo
Pavia, PV, Italy
Hospital of the University of Occupational and Environmental Health, Cardiology, Nephrology
Fukuoka, Japan
Hiroshima University hospital, Cardiovascular Medicine
Hiroshima, Japan
Hiroshima University hospital_Cardiovascular Medicine
Hiroshima, Japan
Kumamoto University Hospital, Cardiovascular Medicine
Kumamoto-shi, Kumamoto, Japan
Shinshu University Hospital, Department of Neurology
Nagano, Japan
Nagasaki University Hospital, Cardiovascular Medicine
Nagasaki, Japan
Okayama University Hospital_Cardiovascular Medicine
Okayama, Japan
UMC Groningen
Groningen, Netherlands
UMC Utrecht
Utrecht, Netherlands
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
Hospital da Senhora da Oliveira - Guimarães
Guimarães, Portugal
ULS Do Alto Ave, E.P.E. - Hospital Senhora da Oliveira - Guimarães
Guimarães, Portugal
ULS De Tras-Os-Montes E Alto Douro E.P.E. - Unidade Hospitalar de Vila Real
Vila Real, Portugal
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.